Logo for University of Iowa Health Care This logo represents the University of Iowa Health Care

Opportunities in Research/Scholarly Projects

Several funding opportunities are listed below for trainees who perform a third year of fellowship. There are visa limitations for several of the grants listed below.  Support for graduate work is also available for fellows who plan a 3rd year of training.

  1. Infectious Diseases Training Grant 
  2. Immunology Training Grant 
  3. Parasitism Training Grant
  4. VA Quality Scholars Program

The Division of Infectious Diseases offers a broad range of research opportunities, with faculty members conducting research in basic laboratory investigation in immunity, translational research, clinical trials, clinical epidemiology, parasitology and a number of other fields. There are also numerous opportunities for collaborative projects with the Clinical Microbiology laboratory staff or investigators in other departments.

  • Dr. Nauseef is the Director of the Inflammation Program, an interdisciplinary basic science research program. This group is active in studying innate immunity and host-pathogen interactions with specific work related to MRSA, Helicobacter pylori, and other pathogens. They are located in the Eckstein Research Building on campus. [see the Inflammation Program website]
  • Dr. Stapleton studies the interactions between flaviviruses including hepatitis C virus and GB virus C with HIV. In addition, he and Drs. Meier and/or Winokur are active in clinical vaccine trials and antiviral therapies with the opportunity for translational research.
  • Dr. Winokur is active in the area of antimicrobial resistance, especially resistance mechanisms and relationships between animal use of antimicrobials and resistance patterns. In addition, she leads the University of Iowa Vaccine Research and Education Unit, one of eight vaccine centers funded by the NIH studying non-HIV vaccines.
  • Dr. Herwaldt has multiple funded studies in areas of infection prevention and molecular epidemiology of healthcare-associated infections. She is co-director of the Emerging Infections Network program.
  • Dr. Wilson studies the pathogenesis, biology, immunology and genetics of Leishmania. She has collaborative projects in Brazil with two adjunct Infectious Diseases faculty members (Drs. Jeronimo and Carvalho) and in India. 
  • Dr. Diekema is the former and now interim Director of the Infectious Diseases Division, a co-director of the UIHC Clinical Microbiology Laboratory, and focuses on areas of antibacterial and antifungal resistance.
  • Dr. Meier studies basic mechanisms of CMV pathogenesis and latency, and he is active in HIV clinical trials.
  • Dr. Polgreen is currently the director of the Emerging Infections Network (EIN), an infectious disease physicians' network sponsored by the CDC and IDSA to detect and gather information on various emerging and re-emerging infections. He is a cofounder of the interdisciplinary Computational Epidemiology Program at the University of Iowa that applies bioinformatics to infectious diseases.
  • Dr. Streit's interests are in general clinical infectious diseases, tropical medicine and Infection Prevention. She is the fellowship Program Director and Director of the Travel Clinic.
  • Dr. Ohl is a member of the VA CADRE group and studies healthcare quality and delivery. He has developed innovative models to provide HIV care to veterans in rural settings via telehealth and to expand TelePrEP use across the state.
  • Dr. Ince directs the Transplant Infectious Disease program. She also has a clinical interest in infections in patients with advanced cardiac support devices. She is the physician champion of the UIHC Antimicrobial Stewardship Program (AMS) and is active in AMS research.
  • Dr. Goto is a member of the Comprehensive Access & Delivery Research & Evaluation Team (CADRE) at the VA. He studies healthcare outcomes and delivery on a national level.  He develops hospital epidemiology policies for the regional VA hospitals.
  • Dr. Livorsi researches healthcare quality and delivery, particularly regarding antimicrobial stewardship.  He is a member of the VA CADRE group.
  • Dr. Sekar is engaged in Ortho ID consultation.
  • Dr. Carvour has an interest in Ortho ID and combines this with a research interest in health equity.

Clinical Research opportunities are available through the following programs/investigators:

  • Vaccine Research and Education Unit (Patricia Winokur, MD, and Jack Stapleton, MD)
  • AIDS Clinical Trials Unit (Jeffery Meier, MD)
  • Computational Epidemiology Program (Philip Polgreen, MD, MPH)
  • Parasitology Program: overseas projects (Mary Wilson, MD, or adjunct professor Selma Jeronimo, MD, PhD)
  • Hospital Epidemiology research (Loreen Herwaldt, MD, or Jorge Salinas, MD)
  • CADRE group at the VA (Eli Perencevich, MD)
  • Antimicrobial Stewardship Program (Dilek Ince, MD, and Daniel Livorsi, MD, MSc)